Message #123 From:
NewsBot Date: January 23, 2007 05:45:00 AM
GILD News Carla A. Hills Joins Gilead Sciences' Board of Directors
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Carla A. Hills
has been appointed to the company’s Board of
Directors, bringing the number of Directors to 10.
Mrs. Hills is the chair and chief executive officer of Hills & Company,
International Consultants, a firm providing advice to U.S. businesses on
investment, trade and risk assessment issues abroad, particularly in
emerging markets. From 1989 to 1993, she served as U.S. Trade
Representative, and was the principal advisor on international trade to
President George H. W. Bush. Mrs. Hills was a Cabinet member under
President Gerald R. Ford as well, serving as Secretary of the Department
of Housing and Urban Development. She also served as Assistant Attorney
General, Civil Division, U.S. Department of Defense.
Mrs. Hills has served on a number of Fortune 100 companies’
Boards, and she currently serves as a member of the International Boards
of J.P. Morgan Chase, American International Group, Rolls Royce and the
Coca-Cola Company. She is also Vice-Chair of the Council on Foreign
Relations, Chair of the Inter-American Dialogue and of the National
Committee on U.S.-China Relations, Co-Chair of the International
Advisory Board of the Center for Strategic and International Studies,
member of the Executive Committee of the Institute for International
Economics and of the Trilateral Commission, and member of the board of
the U.S.-China Business Council and of the International Crisis Group,
among others. Before entering government, Mrs. Hills co-founded and was
partner in a Los Angeles law firm.
“We are very pleased to welcome Carla Hills to
Gilead’s Board of Directors,”
said James M. Denny, Chairman of Gilead’s
Board of Directors. “Carla’s
deep expertise in international trade policy and business will be
invaluable as Gilead continues to grow and further expand its operations
into international markets.”
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the
care of patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in North
America, Europe and Australia.
For more information on Gilead, please call the Gilead Public Affairs
Department at1-800-GILEAD-5 (1-800-445-3235) or visit www.gilead.com.
